nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—MTOR—forebrain—attention deficit hyperactivity disorder	0.0854	0.1	CbGeAlD
Temsirolimus—FKBP1A—forebrain—attention deficit hyperactivity disorder	0.0768	0.09	CbGeAlD
Temsirolimus—MTOR—cardiovascular system—attention deficit hyperactivity disorder	0.0722	0.0846	CbGeAlD
Temsirolimus—FKBP1A—cardiovascular system—attention deficit hyperactivity disorder	0.0649	0.0761	CbGeAlD
Temsirolimus—FKBP1A—midbrain—attention deficit hyperactivity disorder	0.0507	0.0594	CbGeAlD
Temsirolimus—MTOR—nervous system—attention deficit hyperactivity disorder	0.0463	0.0543	CbGeAlD
Temsirolimus—MTOR—central nervous system—attention deficit hyperactivity disorder	0.0446	0.0523	CbGeAlD
Temsirolimus—MTOR—cerebellum—attention deficit hyperactivity disorder	0.0436	0.0511	CbGeAlD
Temsirolimus—FKBP1A—nervous system—attention deficit hyperactivity disorder	0.0417	0.0489	CbGeAlD
Temsirolimus—FKBP1A—central nervous system—attention deficit hyperactivity disorder	0.0401	0.047	CbGeAlD
Temsirolimus—FKBP1A—cerebellum—attention deficit hyperactivity disorder	0.0392	0.046	CbGeAlD
Temsirolimus—MTOR—brain—attention deficit hyperactivity disorder	0.0354	0.0415	CbGeAlD
Temsirolimus—FKBP1A—brain—attention deficit hyperactivity disorder	0.0319	0.0373	CbGeAlD
Temsirolimus—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.0247	0.0289	CbGeAlD
Temsirolimus—FKBP1A—Alpha-synuclein signaling—STUB1—attention deficit hyperactivity disorder	0.0216	0.147	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—STUB1—attention deficit hyperactivity disorder	0.0211	0.144	CbGpPWpGaD
Temsirolimus—ABCB1—forebrain—attention deficit hyperactivity disorder	0.0178	0.0208	CbGeAlD
Temsirolimus—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.015	0.0176	CbGeAlD
Temsirolimus—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.0136	0.016	CbGeAlD
Temsirolimus—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.0134	0.0157	CbGeAlD
Temsirolimus—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.0131	0.0154	CbGeAlD
Temsirolimus—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.0129	0.0151	CbGeAlD
Temsirolimus—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.0126	0.0148	CbGeAlD
Temsirolimus—ABCB1—midbrain—attention deficit hyperactivity disorder	0.0117	0.0137	CbGeAlD
Temsirolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—STUB1—attention deficit hyperactivity disorder	0.0113	0.0767	CbGpPWpGaD
Temsirolimus—CYP2D6—brain—attention deficit hyperactivity disorder	0.0102	0.012	CbGeAlD
Temsirolimus—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00964	0.0113	CbGeAlD
Temsirolimus—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00928	0.0109	CbGeAlD
Temsirolimus—FKBP1A—Alpha-synuclein signaling—SLC6A3—attention deficit hyperactivity disorder	0.00914	0.0622	CbGpPWpGaD
Temsirolimus—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00907	0.0106	CbGeAlD
Temsirolimus—ABCB1—brain—attention deficit hyperactivity disorder	0.00737	0.00864	CbGeAlD
Temsirolimus—FKBP1A—Spinal Cord Injury—RTN4—attention deficit hyperactivity disorder	0.00613	0.0417	CbGpPWpGaD
Temsirolimus—MTOR—FSH signaling pathway—BDNF—attention deficit hyperactivity disorder	0.00467	0.0318	CbGpPWpGaD
Temsirolimus—MTOR—Insulin Signaling—SNAP23—attention deficit hyperactivity disorder	0.00397	0.027	CbGpPWpGaD
Temsirolimus—FKBP1A—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00334	0.0227	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—STUB1—attention deficit hyperactivity disorder	0.00322	0.0219	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—BDNF—attention deficit hyperactivity disorder	0.00255	0.0174	CbGpPWpGaD
Temsirolimus—MTOR—HSF1-dependent transactivation—EP300—attention deficit hyperactivity disorder	0.00246	0.0168	CbGpPWpGaD
Temsirolimus—FKBP1A—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—attention deficit hyperactivity disorder	0.00214	0.0145	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—EP300—attention deficit hyperactivity disorder	0.00214	0.0145	CbGpPWpGaD
Temsirolimus—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00186	0.0126	CbGpPWpGaD
Temsirolimus—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00179	0.0122	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00174	0.0118	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—RTN4—attention deficit hyperactivity disorder	0.0017	0.0116	CbGpPWpGaD
Temsirolimus—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00164	0.0111	CbGpPWpGaD
Temsirolimus—MTOR—Cellular response to heat stress—EP300—attention deficit hyperactivity disorder	0.00159	0.0108	CbGpPWpGaD
Temsirolimus—MTOR—Insulin Signaling—SNAP25—attention deficit hyperactivity disorder	0.00155	0.0106	CbGpPWpGaD
Temsirolimus—MTOR—IFN-gamma pathway—EP300—attention deficit hyperactivity disorder	0.00144	0.00982	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.00122	0.00834	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00121	0.00824	CbGpPWpGaD
Temsirolimus—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00118	0.00805	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—STUB1—attention deficit hyperactivity disorder	0.00113	0.00766	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—STUB1—attention deficit hyperactivity disorder	0.00112	0.00763	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00101	0.00685	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.000888	0.00605	CbGpPWpGaD
Temsirolimus—CYP3A7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000875	0.00596	CbGpPWpGaD
Temsirolimus—CYP3A7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000869	0.00592	CbGpPWpGaD
Temsirolimus—CYP3A7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000863	0.00588	CbGpPWpGaD
Temsirolimus—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000841	0.00573	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000785	0.00534	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000778	0.0053	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MB21D1—attention deficit hyperactivity disorder	0.000705	0.0048	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—STUB1—attention deficit hyperactivity disorder	0.000683	0.00465	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000674	0.00459	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000661	0.0045	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000648	0.00441	CbGpPWpGaD
Temsirolimus—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000633	0.00431	CbGpPWpGaD
Temsirolimus—MTOR—Disease—STUB1—attention deficit hyperactivity disorder	0.00063	0.00429	CbGpPWpGaD
Temsirolimus—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000628	0.00428	CbGpPWpGaD
Temsirolimus—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000624	0.00425	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000589	0.00401	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000565	0.00385	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000562	0.00383	CbGpPWpGaD
Temsirolimus—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00055	0.00374	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—SNAP25—attention deficit hyperactivity disorder	0.000531	0.00362	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000528	0.00359	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000517	0.00352	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000458	0.00312	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00045	0.00306	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000447	0.00304	CbGpPWpGaD
Temsirolimus—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000444	0.00302	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000441	0.00301	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000441	0.003	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000421	0.00286	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.0004	0.00273	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000379	0.00258	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000372	0.00253	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000372	0.00253	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000364	0.00248	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00036	0.00245	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000358	0.00244	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000354	0.00241	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00035	0.00238	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	0.000338	0.0023	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000326	0.00222	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SNAP25—attention deficit hyperactivity disorder	0.000299	0.00203	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000294	0.002	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000292	0.00199	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00029	0.00198	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000259	0.00176	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000258	0.00175	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000247	0.00168	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000247	0.00168	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000243	0.00166	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000228	0.00155	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000226	0.00154	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000225	0.00153	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000209	0.00143	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000205	0.0014	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000203	0.00138	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000199	0.00136	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000198	0.00135	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000197	0.00134	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000195	0.00133	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000188	0.00128	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000188	0.00128	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000184	0.00125	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000183	0.00125	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000181	0.00123	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000179	0.00122	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000179	0.00122	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000176	0.0012	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—EP300—attention deficit hyperactivity disorder	0.000173	0.00118	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000163	0.00111	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	0.00015	0.00102	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000149	0.00101	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000143	0.000972	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000136	0.000926	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000135	0.000918	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000135	0.000918	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000133	0.000903	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000128	0.000874	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000127	0.000865	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000127	0.000865	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000125	0.000851	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000123	0.000839	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000121	0.000823	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00012	0.000819	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000116	0.000791	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	0.000108	0.000737	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000108	0.000734	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000107	0.000732	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—EP300—attention deficit hyperactivity disorder	0.000105	0.000716	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000103	0.000698	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000102	0.000691	CbGpPWpGaD
Temsirolimus—MTOR—Disease—EP300—attention deficit hyperactivity disorder	9.71e-05	0.000661	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.67e-05	0.000658	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	8.3e-05	0.000565	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.3e-05	0.000565	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	8.17e-05	0.000556	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	8.17e-05	0.000556	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.11e-05	0.000552	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	7.7e-05	0.000524	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	7.64e-05	0.00052	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.6e-05	0.000517	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.8e-05	0.000463	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.64e-05	0.000452	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	6.42e-05	0.000437	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.32e-05	0.00043	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	5.03e-05	0.000343	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	5e-05	0.00034	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	4.64e-05	0.000316	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	3.5e-05	0.000238	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	3.3e-05	0.000225	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.16e-05	0.000147	CbGpPWpGaD
